Director Brian Gladden buys 9,985 shares of XRAY at $10.02; cluster of 3 other insiders buying within 14 days amid -40.7% drawdown from 52-week high.
Brian Gladden purchased 9,985 shares for $100,000.00 at $10.02 on 2026-06-15, bringing his holdings from 51.9K to 61.8K shares (+19.3% increase in position size). This buy occurs within a 14-day cluster in which 3 other insiders also purchased shares. Notably, the company is currently unprofitable (full-year net income was negative) with annual revenue declining -3.0%, and the stock is trading -40.7% from its 52-week high of $17.09 while down -17.0% over the past 90 days. The convergence of multiple insider purchases during a period of weak fundamentals and depressed valuation warrant investor attention to whether insiders perceive value at current levels or whether further deterioration is possible.